Pipeline Introduction
Gritgen provides transformative gene therapies by fundamental understanding of the genetics and underlying biology of diseases. The robust pipeline spans from rare diseases to common diseases.
Research Development Progress
Therapeutic areas
Indication
Discovery
Pre-POC
PCC
IND enabling
Phase I
Pivotal trials
Hemophilia A
GS1191
Hereditary angioedema (HAE)
GS1196
Rare disease
Rare disease
Common disease
GS6235
Rare disease
Common disease
Common disease
Common disease
GS5258
Common disease
Common disease
Discovery
Pre-POC
PCC
IND enabling
Phase I
Pivotal trials
Hemophilia A
GS1191
Hereditary angioedema (HAE)
GS1196
Rare disease
Rare disease
Discovery
Pre-POC
PCC
IND enabling
Phase I
Pivotal trials
Common disease
GS6235
Rare disease
Common disease
Common disease
Discovery
Pre-POC
PCC
IND enabling
Phase I
Pivotal trials
Common disease
GS5258
Common disease
Common disease
![comicon02[1].svg](/Public/Uploads/uploadfile/images/20230420/comicon02[1].svg)
![comicon03[1].svg](/Public/Uploads/uploadfile/images/20230420/comicon03[1].svg)
![comimg02638[1].png](/Public/Uploads/uploadfile/images/20230420/comimg02638[1].png)
![comicon04[1].svg](/Public/Uploads/uploadfile/images/20230420/comicon04[1].svg)
